<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="correction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2026.15660</article-id>
<article-id pub-id-type="publisher-id">OL-32-1-15660</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Corrigendum] PVT1 promotes resistance to 5-FU in colon cancer via the miR-486-5p/CDK4 axis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Luo</surname><given-names>Zhuhe</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Ruijun</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Shen</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>Xibin</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>Zhenyi</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>07</month><year>2026</year></pub-date>
<pub-date pub-type="epub"><day>20</day><month>05</month><year>2026</year></pub-date>
<volume>32</volume>
<issue>1</issue>
<elocation-id>305</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2026 Luo et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 24: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="24" page="280" id="RA1" xlink:href="10.3892/ol.2022.13400" ext-link-type="doi">280</related-article>, 2022; DOI: 10.3892/ol.2022.13400</p>
<p>Subsequently to the publication of the above paper, an interested reader drew to the authors&#x0027; attention that, regarding the clone formation assay experiments shown in <xref rid="f6-ol-32-1-15660" ref-type="fig">Fig. 6B</xref> on p. 11, the &#x201C;Mimics NC&#x201D; and &#x201C;Mimics&#x002B;ov&#x002B;CDK4&#x201D; images were apparently matching, suggesting that these data were incorporated into this figure erroneously.</p>
<p>Upon investigating their original data, the authors realized that the representative colony formation image selected for the &#x201C;Mimics NC&#x201D; group had mistakenly been reused for the &#x201C;Mimics&#x002B;ov-CDK4&#x201D; group. The revised version of <xref rid="f6-ol-32-1-15660" ref-type="fig">Fig. 6</xref>, now showing the correct data for the &#x201C;Mimics&#x002B;ov&#x002B;CDK4&#x201D; group in <xref rid="f6-ol-32-1-15660" ref-type="fig">Fig. 6B</xref>, is shown on the next page. Note that this error did not seriously affect the conclusions reported in the paper. All the authors agree with the publication of this Corrigendum, and are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this Corrigendum; moreover, they apologize to the readership for any inconvenience caused.</p>
</body>
<floats-group>
<fig id="f6-ol-32-1-15660" position="float">
<label>Figure 6.</label>
<caption><p>PVT1 regulates colon cancer cell 5-FU resistance via the miR-486-5p/CDK4 axis. (A) CCK-8 assay was used to detect the effects of the PVT1/miR-486-5p/CDK4 regulatory axis on the proliferation of HCT116-5FU-resistant cells. (B and C) A clone formation assay was used to assess the effects of the PVT1/miR-486-5p/CDK4 regulatory axis on clone formation by HCT116-5FU drug-resistant cells. (D) Flow cytometry was used to detect the effect of the PVT1/miR-486-5p/CDK4 regulatory axis on the cell cycle progression of HCT116-5FU drug-resistant cells. &#x002A;P&#x003C;0.05. PVT1, plasmacytoma variant translocation 1; 5-FU, 5-fluorouracil.</p></caption>
<alt-text>PVT1 regulates colon cancer cell 5-FU resistance via the miR-486-5p/CDK4 axis. (A) CCK-8 assay was used to detect the effects of the PVT1/miR-486-5p/CDK4 regulatory axis on the proliferation...</alt-text>
<graphic xlink:href="ol-32-01-15660-g00.tif"/>
</fig>
</floats-group>
</article>
